Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.
about
Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft modelEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastomaMSTN, mTOR and FoxO4 are involved in the enhancement of breast muscle growth by methionine in broilers with lower hatching weight.Maturation of the developing human fetal prostate in a rodent xenograft model.Imprinting genes associated with endometriosis.Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patientsValidation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field designEpigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibilityCOHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis.Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissueProstate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer riskThe dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.The genomic landscape of prostate cancerPrognostic DNA methylation markers for prostate cancer.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Hepcidin regulation in prostate and its disruption in prostate cancer.A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Prostate cancer health disparities: An immuno-biological perspective.
P2860
Q21131794-DA96D9A8-BD77-4527-9CDC-16A9BE0E921FQ27323950-F246011D-7254-4F69-84B1-F318829FED38Q33568125-68BD09A0-D682-4EB7-BE8E-79B57517B16CQ34098218-49539098-2DE4-4339-A72F-5E05B630A6E5Q34601851-DAB8406F-EEEA-423D-B052-B155B92F9128Q34987740-0EAEA542-422F-41E2-9E23-4D2FB8ADB420Q35729124-6F18F474-EFC0-4308-B5CF-FF97B2BCFF5EQ36020932-B4E1A27F-A500-44E5-96EF-5F4AAFBFA25DQ36022437-138D580E-7D08-454A-88C8-C75483901B7CQ36096097-62AB4286-9AA7-4062-95FD-D4A996EA487CQ36616423-B4A98AA0-458D-4C66-A1E8-7ECA8FD11333Q36909749-278AED08-0492-4486-A6D3-F9523763F1D6Q36962421-D7A7700E-1A2F-4EFD-97F0-1FBE04FADAC5Q37055783-3586D849-5265-47BB-9F3C-ED4F4C9758DBQ37059172-653FF1D9-EB14-4659-B976-C9F0530B9822Q37308114-87BE804C-DCEE-44FE-BBA8-3C6D94495F6EQ37692625-166250D8-9CA0-48C2-9F21-3AD0D83BE80AQ37705848-FBBF2A68-7119-4C75-AE0C-B0C9EF5B60EEQ38109474-52FCDF37-E7A2-402A-B1AF-F3FA93C020F9Q38252624-5F86B71C-3ACF-46B8-ACC3-04227551B3DCQ38833395-8FB8187C-A799-4B88-A826-E5A7B7FD43F0Q38889135-B7B48733-B6F5-48B0-9BB1-43BAB2587CE4Q39302302-198A751B-AD0C-48C3-A7BA-F61F1115AD89Q42676794-7854D4B0-D41B-4826-8C9C-1CDA021F5295Q46537204-CACC9BF6-5587-4496-A2A6-85012B750D5A
P2860
Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of new differen ...... nsequences in prostate cancer.
@ast
Identification of new differen ...... nsequences in prostate cancer.
@en
Identification of new differen ...... nsequences in prostate cancer.
@nl
type
label
Identification of new differen ...... nsequences in prostate cancer.
@ast
Identification of new differen ...... nsequences in prostate cancer.
@en
Identification of new differen ...... nsequences in prostate cancer.
@nl
prefLabel
Identification of new differen ...... nsequences in prostate cancer.
@ast
Identification of new differen ...... nsequences in prostate cancer.
@en
Identification of new differen ...... nsequences in prostate cancer.
@nl
P2093
P2860
P50
P1433
P1476
Identification of new differen ...... nsequences in prostate cancer.
@en
P2093
Aubrey R Turner
Shelly Smith
Tracey Young
Wennuan Liu
William B Isaacs
P2860
P304
P356
10.1371/JOURNAL.PONE.0048455
P407
P577
2012-10-31T00:00:00Z